This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Services Related articles in Am J Pathol Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Larson, P. S. Articles by Rosenberg, C. L. Search for Related Content PubMed PubMed Citation Articles by Larson, P. S. Articles by Rosenberg, C. L.

(American Journal of Pathology. 2002;161:283-290.)
© 2002 American Society for Investigative Pathology

Regular Articles

Loss of Heterozygosity or Allele Imbalance in Histologically Normal Breast Epithelium Is Distinct from Loss of Heterozygosity or Allele Imbalance in Co-Existing Carcinomas

Pamela S. Larson^*, Antonio de las Morenas^*, Sheila R. Bennett, L. Adrienne Cupples and Carol L. Rosenberg^*

From the Departments of Pathology and Laboratory Medicine^*and Medicine,Boston University School of Medicine and Boston Medical Center, Boston; and the Department of Epidemiology and Biostatistics,Boston University School of Public Health, Boston, Massachusetts

To better understand early steps in human breast carcinogenesis, we examined allele imbalance or loss of heterozygosity (LOH), in co-existing normal-appearing breast epithelium and cancers. We microdissected a total of 173 histologically normal ducts or terminal ductolobular units (TDLUs) and malignant epithelial samples from 18 breast cancer cases, and examined their DNA for LOH at 21 microsatellite markers on 10 chromosome arms. Fourteen of 109 (13%) normal ducts/TDLUs, from 8 of 18 (44%) cases, contained LOH. The location of these 14 ducts/TDLUs appeared unrelated to distance from the cancer. LOH in normal-appearing epithelium involved only single markers, whereas LOH in cancers commonly encompassed all informative markers on a chromosome arm. In only 1 of 14 (7%) ducts/TDLUs with LOH, was the same LOH seen in the co-existing cancer. Global differences in LOH per arm in normal-appearing tissue were not demonstrated, but less LOH was seen at 11q and 17p than at 1q (P = 0.002), 16q (P = 0.01), and possibly 17q (P = 0.06). These results indicate that in a large fraction of women with breast cancer, histologically normal breast epithelium harbors occult aberrant clones. Individual clones rarely are precursors of co-existing cancers. However, they might constitute a reservoir from which proliferative lesions or second cancers develop once additional genetic abnormalities occur, they could contribute to intratumoral genetic heterogeneity, and they are consistent with a role for genetic instability early in tumorigenesis.

Related articles in Am J Pathol:

This Month in AJP

Am J Pathol 2002 161: 1-2. [Full Text]  

This article has been cited by other articles:

				P. S. Yan, C. Venkataramu, A. Ibrahim, J. C. Liu, R. Z. Shen, N. M. Diaz, B. Centeno, F. Weber, Y.-W. Leu, C. L. Shapiro, et al. Mapping Geographic Zones of Cancer Risk with Epigenetic Biomarkers in Normal Breast Tissue. Clin. Cancer Res., November 15, 2006; 12(22): 6626 - 6636. [Abstract] [Full Text] [PDF]

				B. Xie, J. L. Freudenheim, S. S. Cummings, B. Singh, H. He, S. E. McCann, K. B. Moysich, and P. G. Shields Accurate genotyping from paraffin-embedded normal tissue adjacent to breast cancer Carcinogenesis, February 1, 2006; 27(2): 307 - 310. [Abstract] [Full Text] [PDF]

				P. S. Larson, B. L. Schlechter, A. de las Morenas, J. E. Garber, L. A. Cupples, and C. L. Rosenberg Allele Imbalance, or Loss of Heterozygosity, in Normal Breast Epithelium of Sporadic Breast Cancer Cases and BRCA1 Gene Mutation Carriers Is Increased Compared With Reduction Mammoplasty Tissues J. Clin. Oncol., December 1, 2005; 23(34): 8613 - 8619. [Abstract] [Full Text] [PDF]

				H. BERMAN, J. ZHANG, Y.G. CRAWFORD, M.L. GAUTHIER, C.A. FORDYCE, K.M. McDERMOTT, M. SIGAROUDINIA, K. KOZAKIEWICZ, and T.D. TLSTY Genetic and Epigenetic Changes in Mammary Epithelial Cells Identify a Subpopulation of Cells Involved in Early Carcinogenesis Cold Spring Harb Symp Quant Biol, January 1, 2005; 70(0): 317 - 327. [Abstract] [PDF]

				B. L. Schlechter, Q. Yang, P. S. Larson, A. Golubeva, R. A. Blanchard, A. de Las Morenas, and C. L. Rosenberg Quantitative DNA Fingerprinting May Distinguish New Primary Breast Cancer From Disease Recurrence J. Clin. Oncol., May 15, 2004; 22(10): 1830 - 1838. [Abstract] [Full Text] [PDF]

				L. P. Bignold Carcinogen-induced impairment of enzymes for replicative fidelity of DNA and the initiation of tumours Carcinogenesis, March 1, 2004; 25(3): 299 - 307. [Abstract] [Full Text] [PDF]

				A. K. Meeker, J. L. Hicks, E. Gabrielson, W. M. Strauss, A. M. De Marzo, and P. Argani Telomere Shortening Occurs in Subsets of Normal Breast Epithelium as well as in Situ and Invasive Carcinoma Am. J. Pathol., March 1, 2004; 164(3): 925 - 935. [Abstract] [Full Text] [PDF]